Your session is about to expire
← Back to Search
Hypofractionated Radiotherapy for Prostate Cancer
Study Summary
This trial is testing a shorter schedule for radiation therapy for people with prostate cancer that has come back after surgery. The goal is to find the shortest schedule that people can tolerate without strong side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had radiation in the same area where my prostate is.I am 18 years old or older.I am mostly able to care for myself and carry out daily activities.My prostate cancer has spread outside the pelvis, but not beyond the prostate bed region.I am HIV positive with a stable condition, meeting specific health criteria.I am taking medication that increases the effectiveness of radiation therapy.I need radiation after prostate surgery due to cancer signs or specific surgical findings.I agree to use effective birth control or abstain from sex during and up to 120 days after the study.My prostate cancer diagnosis was confirmed through lab tests.I do not have conditions like IBD, lupus, scleroderma, or radiation sensitivity syndromes.
- Group 1: 1/Prostate bed with integrated boost
- Group 2: 2/Prostate bed irradiation only
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the risks associated with Dose to prostate bed with integrated boost?
"Dose to prostate bed with integrated boost is still being studied for efficacy in Phase 1 trials, so its safety rating is a 1."
How many people are included in this clinical trial at present?
"That is correct. As indicated on the website clinicaltrials.gov, this study was posted on 1/17/2018 and updated on 10/15/2022. They are currently looking for 48 patients from 1 location."
Is this research still looking for participants?
"The study, which was originally posted on January 17th 2018 and updated October 15th of this year, is still recruiting patients."
Share this study with friends
Copy Link
Messenger